Balancing Innovation and Integrity: Student Adoption of Generative Artificial Intelligence for Writing Assignments
IT Professional · 2026-05 · 28 (3) · 52-58
DOI: 10.1109/mitp.2026.3678122 ↗Kurz gefasst
Fachartikel in der Zeitschrift IT Professional, 2026-05. Verfasst von Jonghan Hyun und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
This study examines college students’ adoption of generative artificial intelligence (GenAI) tools, such as ChatGPT, for writing assignments through an adapted technology acceptance model that integrates pragmatic, hedonic, individual, and situational factors. Analysis of survey data from 197 U.S. students revealed that perceived performance and perceived fun significantly enhanced attitudes toward ChatGPT, whereas perceived ease of use, although included in the model, was nonsignificant. Attitude positively predicted intention, but this link weakened under potential academic penalty. Need for cognition strengthened the perceived performance–attitude link but reduced the perceived fun–attitude link. These findings offer insights for researchers seeking to advance understanding of GenAI adoption among students and for educators aiming to design balanced strategies that promote responsible and effective use of GenAI in academic contexts.
Zitieren
APA
Hyun, J., & Slaton, K. (2026). Balancing Innovation and Integrity: Student Adoption of Generative Artificial Intelligence for Writing Assignments. IT Professional, 28(3), 52-58. https://doi.org/10.1109/mitp.2026.3678122
Vancouver
Hyun J, Slaton K. Balancing Innovation and Integrity: Student Adoption of Generative Artificial Intelligence for Writing Assignments. IT Professional. 2026;28(3):52-58. doi:10.1109/mitp.2026.3678122
BibTeX
@article{Hyun2026,
author = {Hyun, Jonghan and Slaton, Kelcie},
title = {Balancing Innovation and Integrity: Student Adoption of Generative Artificial Intelligence for Writing Assignments},
journal = {IT Professional},
year = {2026},
volume = {28},
number = {3},
pages = {52--58},
doi = {10.1109/mitp.2026.3678122}
}
EUVIMED